基本资料 投资组合 财务数据 基金公告
嘉实标普生物科技精选行业ETF(QDII)(159502) |
净值：
0.9799
|
日增长率：
3.43%
|
累计净值：0.9799 | 2025-09-02 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| ALNY | Alnylam Pharmaceuticals Inc | 13,931.00 | 32,519,800.23 | 2.64 |
| EXEL | 伊克力西斯 | 100,402.00 | 31,678,366.65 | 2.57 |
| UTHR | 联合治疗 | 15,046.00 | 30,949,978.74 | 2.51 |
| INSM | Insmed Inc | 42,454.00 | 30,585,623.61 | 2.48 |
| GILD | 吉利德科学 | 38,057.00 | 30,204,850.73 | 2.45 |
| NTRA | Natera Inc | 24,944.00 | 30,166,622.16 | 2.45 |
| REGN | 再生元制药 | 8,021.00 | 30,145,043.57 | 2.45 |
| NBIX | 神经分泌生物科学 | 33,500.00 | 30,142,108.54 | 2.45 |
| MRNA | Moderna Inc | 149,897.00 | 29,605,523.01 | 2.40 |
| INCY | 因塞特医疗 | 60,416.00 | 29,452,839.87 | 2.39 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-06-30 | 99.24 | - | 0.81 | 1,231,192,496.86 |
| 2025-03-31 | 99.48 | - | 2.07 | 1,073,213,261.21 |
| 2024-12-31 | 99.49 | - | 0.59 | 1,062,564,960.47 |
| 2024-09-30 | 99.42 | - | 0.87 | 1,013,082,685.62 |
| 2024-06-30 | 99.23 | - | 3.10 | 850,815,992.73 |
微信公众号
证券之星APP
